Literature DB >> 23463073

Adenoid cystic carcinoma: clinical and molecular features.

Christopher A Moskaluk1.   

Abstract

The clinical features and common molecular alterations of adenoid cystic carcinoma (ACC) are reviewed in this paper. ACC is an uncommon neoplasm that most frequently arises in salivary glands and related tissue in the head and neck region. ACC has distinct histologic features, with cribriform and tubular growth patterns of basaloid cells displaying a predominantly myoepithelial cellular phenotype. This neoplasm also has uncommon clinical features of rare regional lymph node metastasis and a prolonged but relentlessly progressive clinical course. Clinical outcome in ACC is correlated to histologic grade, which is correlated to the degree of aneuploidy and genetic alterations present in the tumor genomes. Recent studies have identified that the majority of ACC contain alterations of the MYB gene, usually resulting in a fusion gene product with the NFIB gene by a t(6;9) translocation event. The molecular consequences of this alteration are incompletely understood, as are secondary molecular alterations that contribute to the neoplastic phenotype of ACC.

Entities:  

Mesh:

Year:  2013        PMID: 23463073      PMCID: PMC3597152          DOI: 10.1007/s12105-013-0426-3

Source DB:  PubMed          Journal:  Head Neck Pathol        ISSN: 1936-055X


  53 in total

1.  C-kit gene mutations in adenoid cystic carcinoma are rare.

Authors:  Christopher A Moskaluk; Henry F Frierson; Adel K El-Naggar; P Andrew Futreal
Journal:  Mod Pathol       Date:  2010-06       Impact factor: 7.842

2.  Determinants and patterns of survival in adenoid cystic carcinoma of the head and neck, including an analysis of adjuvant radiation therapy.

Authors:  Shane Lloyd; James B Yu; Lynn D Wilson; Roy H Decker
Journal:  Am J Clin Oncol       Date:  2011-02       Impact factor: 2.339

3.  Analysis of MYB expression and MYB-NFIB gene fusions in adenoid cystic carcinoma and other salivary neoplasms.

Authors:  Louis B Brill; William A Kanner; André Fehr; Ywonne Andrén; Christopher A Moskaluk; Thomas Löning; Göran Stenman; Henry F Frierson
Journal:  Mod Pathol       Date:  2011-05-13       Impact factor: 7.842

4.  Progressive genetic alterations of adenoid cystic carcinoma with high-grade transformation.

Authors:  Raja R Seethala; Kathleen Cieply; E Leon Barnes; Sanja Dacic
Journal:  Arch Pathol Lab Med       Date:  2011-01       Impact factor: 5.534

5.  MYB expression and translocation in adenoid cystic carcinomas and other salivary gland tumors with clinicopathologic correlation.

Authors:  Robert B West; Christina Kong; Nicole Clarke; Thea Gilks; Joe S Lipsick; Hongbin Cao; Shirley Kwok; Kelli D Montgomery; Sushama Varma; Quynh-Thu Le
Journal:  Am J Surg Pathol       Date:  2011-01       Impact factor: 6.394

6.  Comprehensive analysis of the MYB-NFIB gene fusion in salivary adenoid cystic carcinoma: Incidence, variability, and clinicopathologic significance.

Authors:  Yoshitsugu Mitani; Jie Li; Pulivarthi H Rao; Yi-Jue Zhao; Diana Bell; Scott M Lippman; Randal S Weber; Carlos Caulin; Adel K El-Naggar
Journal:  Clin Cancer Res       Date:  2010-08-11       Impact factor: 12.531

7.  Novel chromosomal rearrangements and break points at the t(6;9) in salivary adenoid cystic carcinoma: association with MYB-NFIB chimeric fusion, MYB expression, and clinical outcome.

Authors:  Yoshitsugu Mitani; Pulivarthi H Rao; P Andrew Futreal; Dianna B Roberts; Philip J Stephens; Yi-Jue Zhao; Li Zhang; Mutsumi Mitani; Randal S Weber; Scott M Lippman; Carlos Caulin; Adel K El-Naggar
Journal:  Clin Cancer Res       Date:  2011-10-05       Impact factor: 12.531

8.  Clinical significance of Myb protein and downstream target genes in salivary adenoid cystic carcinoma.

Authors:  Diana Bell; Dianna Roberts; Matthew Karpowicz; Ehab Y Hanna; Randal S Weber; Adel K El-Naggar
Journal:  Cancer Biol Ther       Date:  2011-10-01       Impact factor: 4.742

9.  Identification of c-kit gene mutations in primary adenoid cystic carcinoma of the salivary gland.

Authors:  Lizette Vila; Hongyan Liu; Samer Z Al-Quran; Dominique P Coco; Hui-Jia Dong; Chen Liu
Journal:  Mod Pathol       Date:  2009-07-17       Impact factor: 7.842

10.  Recurrent fusion of MYB and NFIB transcription factor genes in carcinomas of the breast and head and neck.

Authors:  Marta Persson; Ywonne Andrén; Joachim Mark; Hugo M Horlings; Fredrik Persson; Göran Stenman
Journal:  Proc Natl Acad Sci U S A       Date:  2009-10-19       Impact factor: 11.205

View more
  27 in total

1.  Disparities in Postoperative Therapy for Salivary Gland Adenoid Cystic Carcinomas.

Authors:  Richard J Cassidy; Jeffrey M Switchenko; Mark W El-Deiry; Ryan H Belcher; Jim Zhong; Conor E Steuer; Nabil F Saba; Mark W McDonald; David S Yu; Theresa W Gillespie; Jonathan J Beitler
Journal:  Laryngoscope       Date:  2018-09-08       Impact factor: 3.325

2.  Solid-type adenoid cystic carcinoma of the breast, a distinct molecular entity enriched in NOTCH and CREBBP mutations.

Authors:  Julie Massé; Caroline Truntzer; Romain Boidot; Emmanuel Khalifa; Gaëlle Pérot; Valérie Velasco; Laétitia Mayeur; Claire Billerey-Larmonier; Larry Blanchard; Hélène Charitansky; Isabelle Soubeyran; Richard Iggo; Laurent Arnould; Gaëtan MacGrogan
Journal:  Mod Pathol       Date:  2019-12-19       Impact factor: 7.842

3.  Adenoid Cystic Carcinoma of the Oral Cavity: Radiology-Pathology Correlation.

Authors:  Imran Uraizee; Nicole A Cipriani; Daniel T Ginat
Journal:  Head Neck Pathol       Date:  2017-09-06

4.  Sclerosing Microcystic Adenocarcinoma of the Head and Neck Mucosa: A Neoplasm Closely Resembling Microcystic Adnexal Carcinoma.

Authors:  Anne M Mills; Maria Luisa C Policarpio-Nicholas; Abbas Agaimy; Mark R Wick; Stacey E Mills
Journal:  Head Neck Pathol       Date:  2016-05-27

Review 5.  Adenoid cystic carcinoma: focus on heavy ion therapy and molecular imaging.

Authors:  Angelo Castello; Laura Olivari; Egesta Lopci
Journal:  Am J Nucl Med Mol Imaging       Date:  2018-02-05

6.  Clinical Outcomes and Prognostic Factors of Adenoid Cystic Carcinoma of the Head and Neck.

Authors:  Samuel Jang; Priyesh N Patel; Randall J Kimple; Timothy M McCulloch
Journal:  Anticancer Res       Date:  2017-06       Impact factor: 2.480

7.  Expression of PIM-1 in salivary gland adenoid cystic carcinoma: Association with tumor progression and patients' prognosis.

Authors:  Xin Zhu; Yunfang Yu; Xiuxiu Hou; Jiajie Xu; Zhuo Tan; Xilin Nie; Zhiqiang Ling; Minghua Ge
Journal:  Oncol Lett       Date:  2017-11-14       Impact factor: 2.967

8.  miR-21 regulates tumor progression through the miR-21-PDCD4-Stat3 pathway in human salivary adenoid cystic carcinoma.

Authors:  Lie-Hao Jiang; Ming-Hua Ge; Xiu-Xiu Hou; Jun Cao; Si-Si Hu; Xiao-Xiao Lu; Jing Han; Yi-Chen Wu; Xiang Liu; Xin Zhu; Lian-Lian Hong; Pei Li; Zhi-Qiang Ling
Journal:  Lab Invest       Date:  2015-09-14       Impact factor: 5.662

9.  Study of MYB-NFIB chimeric gene expression, tumor angiogenesis, and proliferation in adenoid cystic carcinoma of salivary gland.

Authors:  Junya Ono; Yasuo Okada
Journal:  Odontology       Date:  2017-12-14       Impact factor: 2.634

10.  Sinonasal tract and nasopharyngeal adenoid cystic carcinoma: a clinicopathologic and immunophenotypic study of 86 cases.

Authors:  Lester D R Thompson; Carla Penner; Ngoc J Ho; Robert D Foss; Markku Miettinen; Jacqueline A Wieneke; Christopher A Moskaluk; Edward B Stelow
Journal:  Head Neck Pathol       Date:  2013-09-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.